Journals / Turkish Journal of Hematology / 2009 / Cilt: 26 - Sayı: 3

Fanconi anemili Türk çocuklarında akut miyeloid lösemi. 1964-1995 döneminde bir merkezin deneyimleri

Acute myeloid leukemia in Turkish children with Fanconi anemia. One center experience in the period between 1964-1995

Pages
118–122
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

AML and solid tomors should be taken into the consideration as the first manifestation of FA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Fanconi’s anemia(FA) is an autosomal recessive disorder characterized by a progressive pancytopenia,variable congenital abnormalities and an increased risk for the development of acute myeloid leukemia (AML).
📊
Key Findings & Data:The objective of this study is to evaluate AML in the patients with FA diagnosed and followed-up in the Department of Pediatric Hematology at Ankara University School of Medicine in the period between 1964-1995.
💡
Conclusion & Impact:AML and solid tomors should be taken into the consideration as the first manifestation of FA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lösemi · miyeloid · akut

Abstract

OBJECTIVE: Fanconi’s anemia(FA) is an autosomal recessive disorder characterized by a progressive pancytopenia,variable congenital abnormalities and an increased risk for the development of acute myeloid leukemia (AML). The objective of this study is to evaluate AML in the patients with FA diagnosed and followed-up in the Department of Pediatric Hematology at Ankara University School of Medicine in the period between 1964-1995. METHODS: A total of 39 patients within the age range 2-14 years( mean 8.2±3.16),28 male and 11 female were diagnosed as FA on the basis of congenital abnormalities,pancytopenia, bone marrow hypoplasia and diepoxybutane induced chromosomal abnormalities that observed in all patients The hereditary and familial basis of FA was apparent in this series.Common abnormalities were growth retardation,cefe’- au- laitspots,hyperpigmentation,microcephaly, finger and thumb deformities,mental retardation and hypogenitalismus RESULTS: Four AML (10.2%) were observed in our series.Cytogenetic analysis of these cases revealed 46/ XX,dup(3)(q22;q26) t(7;17) (p11;p11) in one where it was unsuccessful in three.Two cases could not achieve remission and died.The other two achieved complete remission and remained in remission for2 and 6 months. CONCLUSION: Acute myelomonocytic type in three cases and acute monocytic type in one patient were diagnosed in our series. The patients with FA should be followed with regard to AML and solid tumors. AML and solid tomors should be taken into the consideration as the first manifestation of FA.

Özet

AMAÇ: Fanconi anemisi progresif pansitopeni,çeşitli konjenital anomaliler,akut miyeloid lösemi ve solid tümor geşilme riski çok yüksek olan bir sendromdur.Bu çalışmanın amacı, bölümümüzde 30 yıl içinde izlenen Fanconi anemili hastalarda gelişen AML’nin özelliklerini incelemektir. YÖNTEMLER: Yaşları 2-14 yaş (mean 8,2-3,16) arasında değişen 28’i erkek,11’i kız toplam 39 hasta materyelimizi oluşturdu.Hastalara tanı konjenital anomalilerin varlığı, pansitopeni, kemik iliği hipoplazisi ve diepoksibutan testi ile kromozom kırıklarının gösterilmesiyle kondu. BULGULAR: Hastalarımızda görülen konjenital anomaliler gelişme geriliği,sütlü kahve renginde lekeler,hiperpigmentasyon,mikrosefali,baş parmak ve parmak anomalileri, hipogenitalya ve mental retardasyondu.Hastaların dördünde AML(%10,2) gelişti.Sitogenetik incelemelerde bir hastada 46/XX,dup(3)(q22;q26) t(7;17)(p11;p11) saptandı,diğer üç hastada üreme olmadı.İki hasta remisyona girmedi diğer iki hastada iki ay ve altı ay süren tam remisyon sağlandı. SONUÇ: FA’li hastalar AML ve solid tümörler açısından izlenmelidir.AML ve solid tümörler FA’li hastanın ilk bulgusu olabilir.Hastanın aile bireyleri de malignite yönünden incelenmeli- dir.FA’lı ve AML’li hastalarda prognoz kötüdür.Yeni ve etkin tedavi yöntemleri geliştirilmelidir.

🔖

Cite This Article

GÖZDAŞOĞLU, S., ERTEM, M., UYSAL, Z., BABACAN, E., YÜKSEL, M., BÖKESOY, I., SUNGUROĞLU, A., ARCASOY, A., ÇAVDAR, A. (2009). Fanconi anemili Türk çocuklarında akut miyeloid lösemi. 1964-1995 döneminde bir merkezin deneyimleri. Turkish Journal of Hematology, Cilt: 26 - Sayı: 3, 118–122. https://ajindex.com/articles/413192

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Meetei AR, Levitus M, Xue Y, Medhurst AL, Zwaan M, Ling C, Rooimans MA, Bier P, Hoatlin M, Pals G, de Winter JP, Wang W, Joenje H. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 2004;36:1219-24
  2. Alter BP. Inherited bone marrow failure syndromes. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski’s Hematology of Infancy and Childhood. 6th ed. Philadelphia: W.B. Saunders Company, 2003: 280-99
  3. Kwee ML, Kuyt LP. Fanconi anemia in the Netherlands. In: Schroeder-Kurth TM, Auerbach AD, Obe G, editors. Fanconi Anemia. Clinical Cytogenetic and Experimental Aspects. 1st ed. Berlin Heidelberg: Springer-Verlag, 1989: 18-33
  4. Gözdaşoğlu S, Çavdar AO, Arcasoy A, Babacan E, Sanal Ö. Fanconi’s aplastic anemia. Analysis of 18 cases. Acta Haematol 1980;64:131-5
  5. Akar N, Gözdaşoğlu S. Spectrum of anomalies in Fanconi anemia. Hum Genet 1984;21:75-6
  6. Altay C, Alikaşifoğlu M, Kara A, Tunçbilek E, Özbek N, SchroederKurth TM. Analysis of 65 Turkish patients with congenital aplastic anemia (Fanconi anemia and non-Fanconi anemia): Hacettepe experience. Clin Genet 1997;51:296-302
  7. Altay C, Yetkin S, Pırnar T. Fanconi’s anemia in off-spring of patient with congenital radial and carpal hypoplasia. New Engl J Med 1975;293:151
  8. Koc A, Pronk JC, Alikasifoğlu M, Joenje H, Altay Ç. Variable pathogenicity of exon 43 del (FAA) in four Fanconi anemia patients within a consanguineous family. Br J Haematol 1999;104:127–30
  9. Auerbach AD, Adler B, Chaganti RSK. Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics 1981;67:128-35
  10. Alter B. Diagnostic evaluation of FA. In: Owen J, Frohnmayer L, Eiler ME, editors. Fanconi Anemia. Standards for Clinical Care. 2nd ed. Eugene, OR: Fanconi Anemia Research Fund, Inc., 2003: 3-16
  11. Kook H. Fanconi anemia: current management. Hematology, Proceedings. XXXth World Congress of the International Society of Hematology Sept. 28 – Oct. 2, 2005 Taylor and Francis Group 2005;10(Suppl):108-11
  12. D’Andrea AD. The Fanconi road to cancer. Genes Dev 2003;17:1933-6
  13. Taniguchi T, D’Andrea AD. The Molecular Pathogenesis of Fanconi Anemia: Recent Progress. Blood First Edition Paper, prepublished online February 2, 2006; DOI 10.1182 14. Reid S, Schindler D, Hanenberg H, Barker K, Hanks S, Kalb R, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet 2007;39:162-4
  14. Auerbac